AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32290122 — intervention group
Group type: COMPARATOR
Intervention: Placebo mint
Number of subjects: 56
Study 35381530 — intervention group
Group type: EXPERIMENTAL
Intervention: CHIR-99021 (500, 1,000, 2,000, 5,000, 10,000, 50,000, and 100,000 ng)
Number of subjects: 160
Study 35381530 — intervention group
Group type: COMPARATOR
Intervention: Normal Saline (CON)
Number of subjects: 160
Study 33323501 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute stenting
Number of subjects: 220
Study 33323501 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical thrombectomy (MT)
Number of subjects: 220
Study 33323501 — intervention group
Group type: EXPERIMENTAL
Intervention: Angioplasty and stenting
Number of subjects: 220
Study 33323501 — intervention group
Group type: EXPERIMENTAL
Intervention: Balloon angioplasty and local aspiration
Number of subjects: 220
Study 33323501 — intervention group
Group type: EXPERIMENTAL
Intervention: Not stenting acutely
Number of subjects: 220
Study 33323501 — intervention group
Group type: EXPERIMENTAL
Intervention: General agreement among practitioners
Number of subjects: 220
Study 33323501 — intervention group
Group type: EXPERIMENTAL
Intervention: Willingness to participate in a trial
Number of subjects: 220
Study 34274555 — intervention group
Group type: EXPERIMENTAL
Intervention: Pecan-containing meal
Number of subjects: 10
Study 34274555 — intervention group
Group type: COMPARATOR
Intervention: Control (no nuts)
Number of subjects: 10
Study 34274555 — intervention group
Group type: EXPERIMENTAL
Intervention: Black walnuts
Number of subjects: 10
Study 34274555 — intervention group
Group type: EXPERIMENTAL
Intervention: English walnuts
Number of subjects: 10
Study 34191594 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based palliative care (HBPC)
Number of subjects: 93
Study 32362412 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound guidance for lateral popliteal block
Number of subjects: 0
Study 32362412 — intervention group
Group type: COMPARATOR
Intervention: Nerve stimulation for lateral popliteal block
Number of subjects: 0
Study 32891709 — intervention group
Group type: EXPERIMENTAL
Intervention: n-acetylcysteine 1.2 g
Number of subjects: 9
Study 32891709 — intervention group
Group type: EXPERIMENTAL
Intervention: n-acetylcysteine 2.4 g
Number of subjects: 9
Study 32891709 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 35431792 — intervention group
Group type: EXPERIMENTAL
Intervention: High frequency group (HF group) - MI‐BCI training once per day for 10 sessions
Number of subjects: 16
Study 35431792 — intervention group
Group type: COMPARATOR
Intervention: Low frequency group (LF group) - MI‐BCI training once every other day for 10 sessions
Number of subjects: 16
Study 32588088 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomic model based on 9 selected radiomic features
Number of subjects: 235
Study 32588088 — intervention group
Group type: COMPARATOR
Intervention: Clinical model
Number of subjects: 235
Study 32588088 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex model (combination of radiomic and clinical models)
Number of subjects: 235
Study 32588088 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomic model
Number of subjects: 235
Study 34929381 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical Percutaneous Disc Decompression (PDD)
Number of subjects: 200
Study 34929381 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous Radiofrequency Targeted Disc Decompression (TDD)
Number of subjects: 200
Study 34118709 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive insight measured by the Beck Cognitive Insight Scale (BCIS) - Self-Reflection
Number of subjects: 152
Study 34118709 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive insight measured by the Beck Cognitive Insight Scale (BCIS) - Self-Certainty
Number of subjects: 152
Study 34118709 — intervention group
Group type: COMPARATOR
Intervention: Medication adherence
Number of subjects: 152
Study 34118709 — intervention group
Group type: COMPARATOR
Intervention: Methamphetamine use days
Number of subjects: 152
Study 32776099 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram including age, race, tumor site, depth of tumor invasion, lymph node status, distant metastasis, tumor size, surgery, chemotherapy and radiotherapy.
Number of subjects: 737
Study 32776099 — intervention group
Group type: COMPARATOR
Intervention: SEER stage
Number of subjects: 737
Study 32776099 — intervention group
Group type: COMPARATOR
Intervention: American Joint Committee on Cancer stage
Number of subjects: 737
Study 35596008 — intervention group
Group type: EXPERIMENTAL
Intervention: Canola Oil (CO)
Number of subjects: 282
Study 35596008 — intervention group
Group type: EXPERIMENTAL
Intervention: Sesame Oil (SO)
Number of subjects: 282
Study 35596008 — intervention group
Group type: EXPERIMENTAL
Intervention: Sesame-Canola Oil (SCO)
Number of subjects: 282
Study 33877440 — intervention group
Group type: EXPERIMENTAL
Intervention: NAPP (Free gingival graft + NAPP)
Number of subjects: 40
Study 33877440 — intervention group
Group type: COMPARATOR
Intervention: Control (FGG alone)
Number of subjects: 40
Study 34405878 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter ablation (CA)
Number of subjects: 997
Study 34405878 — intervention group
Group type: COMPARATOR
Intervention: Antiarrhythmic drugs (AADs)
Number of subjects: 997
Study 32299470 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized Tobacco Care Management (PTCM)
Number of subjects: 0
Study 32299470 — intervention group
Group type: COMPARATOR
Intervention: Quitline eReferral
Number of subjects: 0
Study 35435937 — intervention group
Group type: EXPERIMENTAL
Intervention: Awake prone positioning intervention
Number of subjects: 501
Study 35435937 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 501
Study 32820955 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual cycling experience (25-minute, self-paced, facilitated seated)
Number of subjects: 10
Study 32820955 — intervention group
Group type: COMPARATOR
Intervention: Seated physical activity session (time-matched)
Number of subjects: 10
Study 35921023 — intervention group
Group type: EXPERIMENTAL
Intervention: Matcha tea
Number of subjects: 40
Study 35921023 — intervention group
Group type: COMPARATOR
Intervention: Control (LCD diet only)
Number of subjects: 40
Study 32592749 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically increased BMI (by one standard deviation)
Number of subjects: 500000
Study 36468322 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental health training intervention
Number of subjects: 205
Study 33503901 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive esophagectomy (MIE)
Number of subjects: 104
Study 33503901 — intervention group
Group type: COMPARATOR
Intervention: Open esophagectomy (OE)
Number of subjects: 104
Study 32249311 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiopental infusion
Number of subjects: 0
Study 32249311 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34711629 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline serum levels of choline (Q4)
Number of subjects: 692
Study 34711629 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline serum levels of betaine (Q4)
Number of subjects: 692
Study 34711629 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline serum levels of phenylacetylglutamine (Q4)
Number of subjects: 692
Study 34713825 — intervention group
Group type: EXPERIMENTAL
Intervention: Danhong injection
Number of subjects: 0
Study 34713825 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32789505 — intervention group
Group type: COMPARATOR
Intervention: Alum only (control group)
Number of subjects: 320
Study 32789505 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose (2.5 μg/dose)
Number of subjects: 320
Study 32789505 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-dose (5 μg/dose)
Number of subjects: 320
Study 32789505 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose (10 μg/dose)
Number of subjects: 320
Study 32789505 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccine (5 μg/dose) on days 0 and 14
Number of subjects: 320
Study 32789505 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccine (5 μg/dose) on days 0 and 21
Number of subjects: 320
Study 33587542 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-world evidence (RWE)
Number of subjects: 0
Study 33587542 — intervention group
Group type: COMPARATOR
Intervention: Randomized clinical trials (RCTs)
Number of subjects: 0
Study 32259645 — intervention group
Group type: EXPERIMENTAL
Intervention: Interconnected Knotless Anchor (IKA)
Number of subjects: 24
Study 32259645 — intervention group
Group type: COMPARATOR
Intervention: Double Knotless Anchor (DKA)
Number of subjects: 24
Study 32259645 — intervention group
Group type: COMPARATOR
Intervention: Interference Screw (IS)
Number of subjects: 24
Study 34344233 — intervention group
Group type: EXPERIMENTAL
Intervention: Good-quality video
Number of subjects: 388
Study 34344233 — intervention group
Group type: COMPARATOR
Intervention: Poor-quality video
Number of subjects: 388
Study 34344233 — intervention group
Group type: EXPERIMENTAL
Intervention: Good-quality high cholesterol video first
Number of subjects: 388
Study 34344233 — intervention group
Group type: EXPERIMENTAL
Intervention: SDM Process score
Number of subjects: 388
Study 34344233 — intervention group
Group type: COMPARATOR
Intervention: High cholesterol model
Number of subjects: 388
Study 34344233 — intervention group
Group type: COMPARATOR
Intervention: Colorectal cancer model
Number of subjects: 388
Study 32156534 — intervention group
Group type: EXPERIMENTAL
Intervention: Organic Zinc (Zn) 20 mg/kg DM
Number of subjects: 40
Study 32156534 — intervention group
Group type: EXPERIMENTAL
Intervention: Organic Zinc (Zn) 40 mg/kg DM
Number of subjects: 40
Study 32156534 — intervention group
Group type: EXPERIMENTAL
Intervention: Organic Copper (Cu) 12.5 mg/kg DM
Number of subjects: 40
Study 32156534 — intervention group
Group type: EXPERIMENTAL
Intervention: Organic Zinc (Zn) 60 mg/kg DM
Number of subjects: 40
Study 32156534 — intervention group
Group type: EXPERIMENTAL
Intervention: Organic Copper (Cu) 25 mg/kg DM
Number of subjects: 40
Study 32156534 — intervention group
Group type: EXPERIMENTAL
Intervention: Organic Copper (Cu) 37.5 mg/kg DM
Number of subjects: 40
Study 32156534 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Zn 60 + Cu 37.5 mg/kg DM
Number of subjects: 40
Study 32156534 — intervention group
Group type: COMPARATOR
Intervention: Control group (basal diet without mineral supplementation)
Number of subjects: 40
Study 35084071 — intervention group
Group type: EXPERIMENTAL
Intervention: D-cycloserine (DCS) 35 or 70 mg + exposure therapy
Number of subjects: 100
Study 35084071 — intervention group
Group type: COMPARATOR
Intervention: Placebo + exposure therapy
Number of subjects: 100
Study 35084071 — intervention group
Group type: EXPERIMENTAL
Intervention: D-cycloserine (DCS) + exposure therapy
Number of subjects: 100
Study 33934463 — intervention group
Group type: EXPERIMENTAL
Intervention: Allocation to the most densely populated cities
Number of subjects: 0
Study 33934463 — intervention group
Group type: EXPERIMENTAL
Intervention: Random allocation
Number of subjects: 0
Study 33934463 — intervention group
Group type: EXPERIMENTAL
Intervention: Allocation based on the ratio of patients to ICU personnel
Number of subjects: 0
Study 33934463 — intervention group
Group type: EXPERIMENTAL
Intervention: Prioritisation in terms of intrahospital mortality
Number of subjects: 0
Study 33934463 — intervention group
Group type: EXPERIMENTAL
Intervention: Prioritisation of younger populations
Number of subjects: 0
Study 33934463 — intervention group
Group type: EXPERIMENTAL
Intervention: Prioritisation in terms of population mortality
Number of subjects: 0
Study 32011017 — intervention group
Group type: EXPERIMENTAL
Intervention: Environmental exposures (including socio-economic status, water source, sanitary facility, domestic animals, maternal characteristics, season, antibiotic use, and delivery mode)
Number of subjects: 631
Study 32011017 — intervention group
Group type: EXPERIMENTAL
Intervention: Season of stool sample collection
Number of subjects: 631
Study 32011017 — intervention group
Group type: EXPERIMENTAL
Intervention: Type of water source and maternal education
Number of subjects: 631
Study 32011017 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV status
Number of subjects: 631
Study 35787135 — intervention group
Group type: EXPERIMENTAL
Intervention: GCSF (300 μg subcutaneously administered two days after IUI)
Number of subjects: 0
Study 32798161 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF) membranes
Number of subjects: 27
Study 32798161 — intervention group
Group type: COMPARATOR
Intervention: Deproteinized bovine bone and a resorbable collagen membrane
Number of subjects: 27
Study 35846327 — intervention group
Group type: EXPERIMENTAL
Intervention: Progesterone + Metformin
Number of subjects: 219
Study 35846327 — intervention group
Group type: COMPARATOR
Intervention: Progesterone alone
Number of subjects: 219
Study 33044039 — intervention group
Group type: EXPERIMENTAL
Intervention: Irritrol with Er,Cr:YSGG laser
Number of subjects: 90
Study 33044039 — intervention group
Group type: EXPERIMENTAL
Intervention: QMix with diode laser
Number of subjects: 90
Study 33044039 — intervention group
Group type: EXPERIMENTAL
Intervention: QMix with Er,Cr:YSGG laser
Number of subjects: 90
Study 33044039 — intervention group
Group type: EXPERIMENTAL
Intervention: QMix with diode and Er,Cr:YSGG lasers
Number of subjects: 90
Study 33044039 — intervention group
Group type: EXPERIMENTAL
Intervention: Er,Cr:YSGG laser activation
Number of subjects: 90
Study 32060156 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard SWMS care plus a targeted prescribing pathway for LIRA 3 mg
Number of subjects: 384
Study 32060156 — intervention group
Group type: COMPARATOR
Intervention: Standard SWMS care
Number of subjects: 384
Study 616379759 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative care-led meetings
Number of subjects: 0
Study 34895109 — intervention group
Group type: EXPERIMENTAL
Intervention: Lacticaseibacillus rhamnosus GG DSM 33156
Number of subjects: 619
Study 34895109 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 619
Study 32064727 — intervention group
Group type: EXPERIMENTAL
Intervention: Email alert group (n = 362)
Number of subjects: 706
Study 32064727 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 344)
Number of subjects: 706
Study 34153808 — intervention group
Group type: EXPERIMENTAL
Intervention: Corrective exercises and neuromuscular electrical stimulation
Number of subjects: 72
Study 34153808 — intervention group
Group type: COMPARATOR
Intervention: Corrective exercises and sham neuromuscular electrical stimulation
Number of subjects: 72
Study 34669192 — intervention group
Group type: EXPERIMENTAL
Intervention: Strengths-based, culturally responsive family intervention
Number of subjects: 248
Study 32893128 — intervention group
Group type: EXPERIMENTAL
Intervention: Macrogol one sachet in the morning for two days prior to surgery
Number of subjects: 91
Study 32893128 — intervention group
Group type: EXPERIMENTAL
Intervention: Macrogol one sachet, morning and evening of the day prior to surgery
Number of subjects: 91
Study 32893128 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 91
Study 34984549 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition Education and Counseling (NEC) program
Number of subjects: 468
Study 34984549 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 468
Study 33823150 — intervention group
Group type: EXPERIMENTAL
Intervention: Revealed group (selective planned deliveries based on maternal levels of placental growth factor)
Number of subjects: 178
Study 33823150 — intervention group
Group type: COMPARATOR
Intervention: Concealed group (expectant management under usual care)
Number of subjects: 178
Study 36130755 — intervention group
Group type: EXPERIMENTAL
Intervention: RTX+LD CYC
Number of subjects: 100
Study 36130755 — intervention group
Group type: COMPARATOR
Intervention: RTX
Number of subjects: 100
Study 33412557 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifurtimox 10–20 mg/kg/day (aged <12 years) or 8–10 mg/kg/day (aged ≥12 years) for 60 days
Number of subjects: 330
Study 33412557 — intervention group
Group type: COMPARATOR
Intervention: Nifurtimox for 30 days plus placebo for 30 days
Number of subjects: 330
Study 33412557 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifurtimox for 60 days
Number of subjects: 330
Study 33412557 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifurtimox for 30 days
Number of subjects: 330
Study 32848380 — intervention group
Group type: EXPERIMENTAL
Intervention: tiotropium/olodaterol 5/5 µg combination therapy
Number of subjects: 506
Study 32848380 — intervention group
Group type: COMPARATOR
Intervention: tiotropium 5 µg
Number of subjects: 506
Study 32848380 — intervention group
Group type: COMPARATOR
Intervention: olodaterol 5 µg
Number of subjects: 506
Study 32848380 — intervention group
Group type: COMPARATOR
Intervention: tiotropium/olodaterol 5/5 µg
Number of subjects: 506
Study 32848380 — intervention group
Group type: EXPERIMENTAL
Intervention: tiotropium/olodaterol
Number of subjects: 506
Study 36114137 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 6262
Study 32916655 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast Tempo (FT) hexagonal‐barbell deadlifts
Number of subjects: 8
Study 32916655 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow Tempo (ST) hexagonal‐barbell deadlifts
Number of subjects: 8
Study 35301982 — intervention group
Group type: EXPERIMENTAL
Intervention: Shockwave lithotripsy
Number of subjects: 607
Study 35301982 — intervention group
Group type: COMPARATOR
Intervention: Ureteroscopic stone treatment
Number of subjects: 607
Study 32342158 — intervention group
Group type: EXPERIMENTAL
Intervention: Full percutaneous interbody fusion technique with posterior stabilization using rods and screws and an 8-mm-width intradiscal cage
Number of subjects: 79
Study 35930976 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow normobaric oxygen (NBO) by Venturi mask (FiO2 50%, flow 15 L/min) for 6 hours
Number of subjects: 87
Study 35930976 — intervention group
Group type: COMPARATOR
Intervention: Routine low-flow oxygen supplementation by nasal cannula (flow 3 L/min) for 6 hours
Number of subjects: 87
Study 35930976 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow normobaric oxygen (NBO)
Number of subjects: 87
Study 35930976 — intervention group
Group type: COMPARATOR
Intervention: Routine low-flow oxygen supplementation by nasal cannula
Number of subjects: 87
Study 33610902 — intervention group
Group type: COMPARATOR
Intervention: Dietary crude protein (CP) level at 17.5%
Number of subjects: 720
Study 33610902 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary crude protein (CP) level at 16.5%
Number of subjects: 720
Study 33610902 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary crude protein (CP) level at 15.5%
Number of subjects: 720
Study 33610902 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary crude protein (CP) level at 14.5%
Number of subjects: 720
Study 33610902 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary crude protein (CP) level at 13.5%
Number of subjects: 720
Study 33610902 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary crude protein (CP) levels
Number of subjects: 720
Study 32677170 — intervention group
Group type: EXPERIMENTAL
Intervention: Doublebase gel (DBG)
Number of subjects: 0
Study 32677170 — intervention group
Group type: COMPARATOR
Intervention: Myribase gel (MBG)
Number of subjects: 0
Study 35219776 — intervention group
Group type: EXPERIMENTAL
Intervention: Olaparib (300 mg twice a day) with RDI >98%
Number of subjects: 185
Study 35219776 — intervention group
Group type: EXPERIMENTAL
Intervention: Olaparib (300 mg twice a day) with RDI 90%-98%
Number of subjects: 185
Study 35219776 — intervention group
Group type: EXPERIMENTAL
Intervention: Olaparib (300 mg twice a day) with RDI <90%
Number of subjects: 185
Study 32642957 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal (IN) ketamine (30 and 50 mg)
Number of subjects: 21
Study 32642957 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 35986383 — intervention group
Group type: EXPERIMENTAL
Intervention: Wedge-cut Weil osteotomy
Number of subjects: 80
Study 35986383 — intervention group
Group type: COMPARATOR
Intervention: Flat-cut Weil osteotomy
Number of subjects: 80
Study 34330204 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Mindful Hypnosis (BMH)
Number of subjects: 55
Study 34330204 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Training (CT)
Number of subjects: 55
Study 33405182 — intervention group
Group type: EXPERIMENTAL
Intervention: One anastomosis gastric bypass (OAGB) in patients with hiatus hernia (HH)
Number of subjects: 89
Study 33405182 — intervention group
Group type: EXPERIMENTAL
Intervention: One anastomosis gastric bypass (OAGB) in patients with preoperative GORD on PPI
Number of subjects: 89
Study 36169690 — intervention group
Group type: EXPERIMENTAL
Intervention: SP+DS method
Number of subjects: 795
Study 36169690 — intervention group
Group type: EXPERIMENTAL
Intervention: ACR-TIRADS combined with Kwak-TIRADS in parallel
Number of subjects: 795
Study 36169690 — intervention group
Group type: EXPERIMENTAL
Intervention: C-TIRADS combined with EU-TIRADS in serial
Number of subjects: 795
Study 36169690 — intervention group
Group type: EXPERIMENTAL
Intervention: DS for inconsistently diagnosed nodules
Number of subjects: 795
Study 36169690 — intervention group
Group type: EXPERIMENTAL
Intervention: Kwak-TIRADS
Number of subjects: 795
Study 36169690 — intervention group
Group type: EXPERIMENTAL
Intervention: EU-TIRADS
Number of subjects: 795
Study 34020856 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-form TCR data accuracy rates
Number of subjects: 700
Study 32895283 — intervention group
Group type: EXPERIMENTAL
Intervention: Description-based risk education intervention
Number of subjects: 0
Study 32895283 — intervention group
Group type: EXPERIMENTAL
Intervention: Experience-based risk education intervention
Number of subjects: 0
Study 32895283 — intervention group
Group type: COMPARATOR
Intervention: Both interventions (description-based and experience-based)
Number of subjects: 0
Study 35842700 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component intervention including peer education camps, menstrual hygiene laboratories, mother's outreach sessions, community meetings, and improvements to school WASH facilities over a three-month period.
Number of subjects: 50
Study 35842700 — intervention group
Group type: COMPARATOR
Intervention: Control group (25 schools without the intervention).
Number of subjects: 50
Study 35842700 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component intervention.
Number of subjects: 50